| GSK PLC LS-,3125 |
| Großbritannien |
| Gesundheit |
| GB00BN7SWP63 / A3DMB5 |
| GS71 (Frankfurt) |
| FRA:GS71, ETR:GS71, GS71:GR |
| FTSE100 |
| https://www.gsk.com/ |
|
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. The company focuses on discovering, developing, and manufacturing prescription medicines and vaccines for a wide range of diseases. GSK plc ..
>Volltext.. |
| 87459.17 Mio. EUR |
| 104488.82 Mio. EUR |
| 37989.6 Mio. EUR |
| 12020.56 Mio. EUR |
| 5516 Mio. EUR |
| 1.37 EUR |
| 20867.22 Mio. EUR |
| 3552.62 Mio. EUR |
| 9064.05 Mio. EUR |
| 0.14 |
| 4.56% |
| 40.29% |
| 0.78 EUR |
| 3.63% |
| 3.73% |
| 13.08.26 - 0.19873€ 14.05.26 - 0.194752€ >weitere anzeigen... |
| - |
| GSK, GLAXOSMITHKLINE, GLAXO |
| 04.09.26 |
|
||||
|